RNU2-34P

Across TCGA pan-cancer cohorts, RNU2-34P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU2-34P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU2-34P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU2-34P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, HNSC, and OV are the cancer types where RNU2-34P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.231	0.638	<.001	102	view →
HNSC	DFS	Tertile	III,IV	0.306	0.580	.003	69	view →
OV	OS	Tertile	All	0.547	0.711	<.001	54	view →
BLCA	DFS	Tertile	All	0.242	0.512	.011	36	view →
ESCA	DFS	Tertile	III,IV	0.622	0.258	.006	36	view →
CESC	DFS	Tertile	All	0.439	0.743	.030	18	view →
LAML	DFS	Tertile	All	0.096	0.579	<.001	18	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	18	view →
KIRP	DFS	Tertile	III,IV	0.191	0.720	.003	9	view →
LGG	OS	Tertile	All	0.592	0.814	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU2-34P–KIRC (OS)

Open the KIRC breakdown →